City of Chicago v. Purdue Pharma L.P., 211 F. Supp. 3d 1058

Background

The City of Chicago sued multiple opioid manufacturers alleging deceptive and unfair marketing caused physicians to prescribe opioids for long‑term chronic pain, resulting in over $13 million in City‑paid prescriptions and related municipal costs.
Claims included municipal consumer‑fraud (ICFA analog) and Chicago ordinance violations, false statements/false claims, insurance fraud, conspiracy, unjust enrichment, and cost‑recovery for municipal services.
SAC alleges branded and unbranded marketing (sales reps, speakers, front groups, key opinion leaders) misstated benefits, downplayed addiction and withdrawal, promoted opioids over NSAIDs, and caused prescribers to certify medical necessity.
Defendants moved to dismiss under Rule 12(b)(6) and Rule 9(b) and sought a stay/dismissal under the primary‑jurisdiction doctrine.
Court denied primary‑jurisdiction stay, held most consumer‑fraud/misrepresentation claims survive Rule 9(b)/12(b)(6), but dismissed (without prejudice) Counts II and IV–X for pleading defects (principally lack of a clear link between named prescribers who heard marketing and named prescribers whose paid prescriptions appear in City exhibits).

Issues

Issue	Plaintiff's Argument	Defendant's Argument	Held
Primary jurisdiction / stay	No new basis to defer to FDA; courts can decide whether marketing was deceptive	FDA investigations and label issues warrant deferral/stay	Denied — court declines primary‑jurisdiction stay; claims about deceptive marketing are adjudicable by courts
Rule 9(b) particularity for fraud/ICFA claims	SAC identifies misstatements, named Chicago prescribers (by letter), and will link names in discovery; defendants track rep visits	SAC lumps defendants and lacks particularized "who/what/when" tying each defendant to specific misleading statements	Granted in part: Court finds ICFA/misrepresentation claims pleaded with sufficient particularity under relaxed 9(b) standards
False statements / false claims (express vs. implied certification; materiality)	City: defendants caused prescribers to (expressly or impliedly) certify medical necessity, enabling false claims; Universal Health allows implied‑certification theory	Defendants: no express certification alleged; Seventh Circuit rejected implied‑certification; alleged misrepresentations immaterial given routine payments and FDA labels	Dismissed without prejudice: Court allows implied‑certification post‑Universal Health but finds City failed to plead materiality sufficiently and failed to tie prescribers who heard misrepresentations to paid claims; leave to amend
Causation / proximate cause linking marketing → paid claims → municipal costs	City: marketing foreseeably led to prescriptions and City payments; exhibits list paid prescriptions; reliance can be inferred	Defendants: intervening events (physician judgment, patient actions, payor decisions) break causal chain; plaintiffs must plead which misrepresentations caused which prescriptions	Dismissed without prejudice for several counts where the SAC failed to connect named prescribers who received marketing with named prescribers in City claim exhibits; but court indicates foreseeability standard can support causation if link provided

Key Cases Cited

Richards v. Mitcheff, 696 F.3d 635 (7th Cir.) (Rule 12(b)(6) standard)
Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility pleading standard)
Ashcroft v. Iqbal, 556 U.S. 662 (pleading standards; legal conclusions vs. factual allegations)
Pirelli Armstrong Tire Corp. Retiree Med. Benefits Tr. v. Walgreen Co., 631 F.3d 436 (9(b) applies to ICFA fraud claims)
U.S. ex rel. Lusby v. Rolls‑Royce Corp., 570 F.3d 849 (9(b) who/what/when/where/how)
Corley v. Rosewood Care Ctr., Inc., 142 F.3d 1041 (relaxed 9(b) where plaintiff lacks access to facts)
Borsellino v. Goldman Sachs Grp., Inc., 477 F.3d 502 (Rule 9(b) applies to averments of fraud; elements of civil conspiracy)
United States v. W. Pac. Ry. Co., 352 U.S. 59 (primary‑jurisdiction doctrine context)
Oliveira v. Amoco Oil Co., 201 Ill.2d 134 (public‑enforcement under ICFA need not allege actual deception or injury)
Kim v. Carter’s Inc., 598 F.3d 362 (public enforcement and ICFA: deceptive practice actionable without showing actual deception)
Universal Health Servs., Inc. v. United States ex rel. Escobar, 136 S. Ct. 1989 (Supreme Court) (implied‑certification theory valid; demanding materiality standard)
Allison Engine Co. v. United States ex rel. Sanders, 553 U.S. 662 (FCA causation principles referenced)
U.S. ex rel. Watson v. King‑Vassel, 728 F.3d 707 (intervening events may be foreseeable; causation in FCA context)